Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies
Background Thiophene(s) are an important group in therapeutic applications, and sulfonamides are the most important class of carbonic anhydrase (CA) inhibitors. In this study, inhibition effects of some thiophene-based sulfonamides on human erythrocytes carbonic anhydrase I and II isoenzymes (hCA-I...
Saved in:
Published in | Pharmacological reports Vol. 72; no. 6; pp. 1738 - 1748 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.12.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Thiophene(s) are an important group in therapeutic applications, and sulfonamides are the most important class of carbonic anhydrase (CA) inhibitors. In this study, inhibition effects of some thiophene-based sulfonamides on human erythrocytes carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) were investigated. Thiophene-based sulfonamides used in this study showed potent inhibition effect on both isoenzymes at very small concentrations.
Materials and methods
We report on the purification of the carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) using affinity chromatography method. The inhibition effect of the thiophene-based sulfonamides was determined by IC
50
and K
i
parameters. A molecular docking study was performed for each molecule.
Results
Thiophene-based sulfonamides showed IC
50
values of in the range of 69 nM to 70 µM against hCA-I, 23.4 nM to 1.405 µM against hCA-II. K
i
values were in the range of 66.49 ± 17.15 nM to 234.99 ± 15.44 µM against hCA-I, 74.88 ± 20.65 nM to 38.04 ± 12.97 µM against hCA-II. Thiophene-based sulfonamides studied in this research showed noncompetitive inhibitory properties on both isoenzymes. To elucidate the mechanism of inhibition, a molecular docking study was performed for molecules 1 and 4 exhibiting a strong inhibitory effect on hCA-I and hCA-II. The compounds inhibit the enzymes by interacting out of catalytic active site. The sulfonamide and thiophene moiety played a significant role in the inhibition of the enzymes.
Conclusion
We hope that this study will contribute to the design of novel thiophene-based sulfonamide derived therapeutic agents that may be carbonic anhydrase inhibitors in inhibitor design studies. |
---|---|
AbstractList | Background
Thiophene(s) are an important group in therapeutic applications, and sulfonamides are the most important class of carbonic anhydrase (CA) inhibitors. In this study, inhibition effects of some thiophene-based sulfonamides on human erythrocytes carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) were investigated. Thiophene-based sulfonamides used in this study showed potent inhibition effect on both isoenzymes at very small concentrations.
Materials and methods
We report on the purification of the carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) using affinity chromatography method. The inhibition effect of the thiophene-based sulfonamides was determined by IC
50
and K
i
parameters. A molecular docking study was performed for each molecule.
Results
Thiophene-based sulfonamides showed IC
50
values of in the range of 69 nM to 70 µM against hCA-I, 23.4 nM to 1.405 µM against hCA-II. K
i
values were in the range of 66.49 ± 17.15 nM to 234.99 ± 15.44 µM against hCA-I, 74.88 ± 20.65 nM to 38.04 ± 12.97 µM against hCA-II. Thiophene-based sulfonamides studied in this research showed noncompetitive inhibitory properties on both isoenzymes. To elucidate the mechanism of inhibition, a molecular docking study was performed for molecules 1 and 4 exhibiting a strong inhibitory effect on hCA-I and hCA-II. The compounds inhibit the enzymes by interacting out of catalytic active site. The sulfonamide and thiophene moiety played a significant role in the inhibition of the enzymes.
Conclusion
We hope that this study will contribute to the design of novel thiophene-based sulfonamide derived therapeutic agents that may be carbonic anhydrase inhibitors in inhibitor design studies. BACKGROUNDThiophene(s) are an important group in therapeutic applications, and sulfonamides are the most important class of carbonic anhydrase (CA) inhibitors. In this study, inhibition effects of some thiophene-based sulfonamides on human erythrocytes carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) were investigated. Thiophene-based sulfonamides used in this study showed potent inhibition effect on both isoenzymes at very small concentrations. MATERIALS AND METHODSWe report on the purification of the carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) using affinity chromatography method. The inhibition effect of the thiophene-based sulfonamides was determined by IC50 and Ki parameters. A molecular docking study was performed for each molecule. RESULTSThiophene-based sulfonamides showed IC50 values of in the range of 69 nM to 70 µM against hCA-I, 23.4 nM to 1.405 µM against hCA-II. Ki values were in the range of 66.49 ± 17.15 nM to 234.99 ± 15.44 µM against hCA-I, 74.88 ± 20.65 nM to 38.04 ± 12.97 µM against hCA-II. Thiophene-based sulfonamides studied in this research showed noncompetitive inhibitory properties on both isoenzymes. To elucidate the mechanism of inhibition, a molecular docking study was performed for molecules 1 and 4 exhibiting a strong inhibitory effect on hCA-I and hCA-II. The compounds inhibit the enzymes by interacting out of catalytic active site. The sulfonamide and thiophene moiety played a significant role in the inhibition of the enzymes. CONCLUSIONWe hope that this study will contribute to the design of novel thiophene-based sulfonamide derived therapeutic agents that may be carbonic anhydrase inhibitors in inhibitor design studies. |
Author | Alım, Zuhal Karaman, Muhammet Köksal, Zeynep |
Author_xml | – sequence: 1 givenname: Zuhal surname: Alım fullname: Alım, Zuhal organization: Department of Chemistry, Faculty of Science and Arts, Kırşehir Ahi Evran University – sequence: 2 givenname: Zeynep surname: Köksal fullname: Köksal, Zeynep email: zeynep.koksal@medeniyet.edu.tr organization: Department of Chemistry, Faculty of Engineering and Natural Sciences, Istanbul Medeniyet University – sequence: 3 givenname: Muhammet surname: Karaman fullname: Karaman, Muhammet organization: Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Kilis 7 Aralık University |
BookMark | eNp9kc1u1TAQhS1UJG4LL8DKSzYB_107WaKqwJUqsYG15diTxiWxLx4HKTwaT4fby5rFaM7ifEczOtfkKuUEhLzl7D1nzHxAJZViHRNtGFdDp16QgxDD0B11r67IgRupOs4Ve0WuER8ZU1zI44H8ufvlls3VmBPNE8W8Aq1zzOcZEnSjQwgUt2XKya0xAFKH9JwrpEpjmuMYay74RHpXxpyipy7NeygNpKemAz2daMQM6fe-NrzJxdUWOpW80nlbXaJQ9jqX7PfaDONOf8QE9Tkp0DUv4LfFlaYCLEtMDxTrFiLga_JycgvCm3_7hnz_dPft9kt3__Xz6fbjfeelULUT4zQqM-nAmRTc6HHoJ8_80agAik9aadM74bVmAvwwCO57wxyMRjN11DrIG_Luknsu-ecGWO0a0bdbXIK8oRVKMmkG1ffNKi5WXzJigcmeS1xd2S1n9qkoeynKtqLsc1FWNUheIGzm9ADFPuatpPbS_6i_O6-cxw |
CitedBy_id | crossref_primary_10_1002_slct_202204191 crossref_primary_10_1016_j_jfca_2023_105842 crossref_primary_10_1016_j_molstruc_2022_132630 crossref_primary_10_1016_j_eurpolymj_2024_112930 crossref_primary_10_1016_j_rechem_2023_101174 crossref_primary_10_1002_bdd_2309 crossref_primary_10_1016_j_molstruc_2021_130498 crossref_primary_10_1016_j_molstruc_2022_133647 crossref_primary_10_1134_S1068162022040124 crossref_primary_10_1002_aoc_6537 crossref_primary_10_1016_j_ijbiomac_2021_08_128 crossref_primary_10_2174_0929867329666220722143547 crossref_primary_10_17714_gumusfenbil_1359988 crossref_primary_10_1002_cbdv_202300207 |
Cites_doi | 10.1517/13543776.2013.780598 10.1016/j.molstruc.2020.127868 10.3109/14756366.2015.1122001 10.1038/nature04710 10.1016/j.bioorg.2020.103762 10.1517/13543776.14.5.667 10.1038/227680a0 10.1016/j.bioorg.2018.12.012 10.1002/jbt.22421 10.1051/jbio:2007014 10.1021/cr200176r 10.1016/0003-2697(76)90527-3 10.1002/jbt.22300 10.2174/0929867033457647 10.1016/j.bmc.2015.02.027 10.4155/fmc.14.68 10.1517/13543776.2013.790957 10.1517/13543776.2013.798648 10.1111/cbdd.12561 10.1016/j.bmc.2007.04.020 10.1016/j.bioorg.2020.103839 10.1016/j.molstruc.2018.11.038 10.1002/ardp.201800359 10.1016/j.bioorg.2019.103468 10.1186/s13065-018-0511-5 10.1021/ja01318a036 10.1016/j.bioorg.2019.103213 10.3390/molecules22101642 10.1080/17460441.2017.1253677 10.1517/13543776.2013.778246 10.1002/jbt.22194 10.3109/14756366.2013.787422 10.1016/S0169-409X(00)00129-0 10.1039/C4CC07320G 10.1016/S0021-9258(18)95800-X 10.1016/S0021-9258(18)51011-5 |
ContentType | Journal Article |
Copyright | Maj Institute of Pharmacology Polish Academy of Sciences 2020 |
Copyright_xml | – notice: Maj Institute of Pharmacology Polish Academy of Sciences 2020 |
DBID | AAYXX CITATION 7X8 |
DOI | 10.1007/s43440-020-00149-4 |
DatabaseName | CrossRef MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2299-5684 |
EndPage | 1748 |
ExternalDocumentID | 10_1007_s43440_020_00149_4 |
GroupedDBID | --- --M 123 29O 2WC 3EA 4.4 406 457 53G 7-5 8P~ AACTN AAEDT AAFGU AAHNG AAIKJ AAKOC AALRI AAOAW AATNV AAUYE AAXLA AAXUO AAYFA ABECU ABFRF ABJNI ABKAS ABMQK ABMZM ABTEG ABTKH ABXDB ABYKQ ACDAQ ACGFO ACGFS ACHSB ACIGE ACTTH ACVWB ACWMK ADBBV ADEZE ADOXG ADTPH ADYFF AEFTE AEFWE AEKER AENEX AESKC AESTI AFNRJ AFQWF AFTJW AGHFR AGMZJ AGUBO AILAN AITUG AJBFU AJDOV AJOXV AJZVZ ALMA_UNASSIGNED_HOLDINGS AMFUW AMTXH AMXSW AMYLF ANZVX BAWUL BGNMA BLXMC DIK DPUIP E3Z EBLON EBS EJD F5P FDB FEDTE FIRID FNLPD GBLVA GX1 HH5 HVGLF IKXTQ IWAJR JZLTJ KOV LLZTM M4Y M~E NPVJJ NQJWS NU0 OAUVE PT4 RNS ROL RSV SNE SNPRN SOHCF SOJ SRMVM SSLCW SSZ T5K TR2 UNMZH XSB Y2W ZMTXR ~G- 0R~ AACDK AAJBT AASML AAYXX ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AIGIU CITATION FIGPU SJYHP 7X8 |
ID | FETCH-LOGICAL-c324t-2bfb47f6d1032176b98fc0c574de41f64678a2c6602ec9921c870aeb7604566d3 |
ISSN | 1734-1140 |
IngestDate | Fri Oct 25 08:39:00 EDT 2024 Thu Sep 12 19:42:51 EDT 2024 Sat Dec 16 12:01:24 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Sulfonamide Molecular modelling Thiophene Inhibition Carbonic anhydrase |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c324t-2bfb47f6d1032176b98fc0c574de41f64678a2c6602ec9921c870aeb7604566d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PQID | 2430379488 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2430379488 crossref_primary_10_1007_s43440_020_00149_4 springer_journals_10_1007_s43440_020_00149_4 |
PublicationCentury | 2000 |
PublicationDate | 2020-12-01 |
PublicationDateYYYYMMDD | 2020-12-01 |
PublicationDate_xml | – month: 12 year: 2020 text: 2020-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham |
PublicationTitle | Pharmacological reports |
PublicationTitleAbbrev | Pharmacol. Rep |
PublicationYear | 2020 |
Publisher | Springer International Publishing |
Publisher_xml | – name: Springer International Publishing |
References | Alım (CR16) 2018; 32 Sanguinetti, Tristani-Firouzi (CR34) 2006; 440 Carta, Supuran (CR8) 2013; 23 Wilbur, Anderson (CR18) 1948; 176 Bradford (CR19) 1976; 72 Supuran (CR41) 2016; 31 Supuran, Scozzafava (CR14) 2007; 15 Taslimi, Turkan, Çetin, Burhan, Karaman, Bildirici (CR29) 2019; 92 Karimov, Orujova, Taslimi, Sadeghian, Mammadov, Karaman (CR37) 2020; 99 Koksal, Alım, Bayrak, Gulcin, Ozdemir (CR17) 2019; 33 CR30 Capasso, Supuran (CR3) 2014; 29 Lineweaver, Burk (CR22) 1934; 56 Burmaoglu, Akin-Kazancioglu, Kaya, Kazancioglu, Karaman, Algul (CR39) 2020; 1208 Lipinski, Lombardo, Dominy, Feeney (CR36) 2001; 46 Alım, Kilinc, Sengul, Beydemir (CR15) 2015; 86 Laemmli (CR20) 1970; 227 Scozzafava, Owa, Mastrolorenzo, Supuran (CR4) 2003; 10 Shah, Verma (CR35) 2018; 12 (CR33) 2019 Turkan, Cetin, Taslimi, Karaman, Gulcin (CR32) 2019; 352 Monti, Supuran, De Simone (CR5) 2013; 23 Loubatières-Mariani (CR7) 2007; 201 Alterio, Di Fiore, D’Ambrosio, Supuran, De Simone (CR11) 2012; 112 Supuran (CR12) 2013; 23 Carta, Di Cesare, Pinard, Ghelardini, Scozzafava, McKenna, Supuran (CR9) 2015; 23 Verpoorte, Mehta, Edsall (CR21) 1967; 242 CR28 CR26 Bal, Kaya, Gök, Taslimi, Aktaş, Karaman (CR27) 2020; 94 CR23 Kalin, Koksal, Kalin, Karaman, Gulcin, Ozdemir (CR24) 2020; 34 Scozzafava, Mastrolorenzo, Supuran (CR13) 2004; 14 Yigit, Kaya, Taslimi, Isık, Karaman, Yigit (CR31) 2019; 1179 Carta, Supuran, Scozzafava (CR10) 2014; 6 Supuran (CR1) 2017; 12 D’Ambrosio, Carradori, Monti, Buonanno, Secci, Vullo (CR40) 2015; 51 Supuran (CR2) 2017; 22 Scozzafava, Supuran, Carta (CR6) 2013; 23 Bayrak, Taslimi, Karaman, Gulcin, Menzek (CR25) 2019; 85 Singh, Swain, Thacker, Sigalapalli, Yadav, Angeli (CR38) 2020; 99 Z Koksal (149_CR17) 2019; 33 K D’Ambrosio (149_CR40) 2015; 51 F Carta (149_CR9) 2015; 23 149_CR30 Induced Fit Docking protocol; Glide (149_CR33) 2019 MC Sanguinetti (149_CR34) 2006; 440 A Scozzafava (149_CR13) 2004; 14 S Burmaoglu (149_CR39) 2020; 1208 F Carta (149_CR10) 2014; 6 CA Lipinski (149_CR36) 2001; 46 CT Supuran (149_CR12) 2013; 23 MM Bradford (149_CR19) 1976; 72 A Scozzafava (149_CR6) 2013; 23 F Turkan (149_CR32) 2019; 352 F Carta (149_CR8) 2013; 23 P Taslimi (149_CR29) 2019; 92 A Scozzafava (149_CR4) 2003; 10 S Bal (149_CR27) 2020; 94 R Shah (149_CR35) 2018; 12 149_CR26 A Karimov (149_CR37) 2020; 99 CT Supuran (149_CR2) 2017; 22 H Lineweaver (149_CR22) 1934; 56 149_CR28 MM Loubatières-Mariani (149_CR7) 2007; 201 149_CR23 B Yigit (149_CR31) 2019; 1179 R Kalin (149_CR24) 2020; 34 C Bayrak (149_CR25) 2019; 85 CT Supuran (149_CR1) 2017; 12 SM Monti (149_CR5) 2013; 23 V Alterio (149_CR11) 2012; 112 UK Laemmli (149_CR20) 1970; 227 CT Supuran (149_CR41) 2016; 31 JA Verpoorte (149_CR21) 1967; 242 C Capasso (149_CR3) 2014; 29 CT Supuran (149_CR14) 2007; 15 Z Alım (149_CR15) 2015; 86 KM Wilbur (149_CR18) 1948; 176 P Singh (149_CR38) 2020; 99 Z Alım (149_CR16) 2018; 32 |
References_xml | – volume: 23 start-page: 681 year: 2013 end-page: 691 ident: CR8 article-title: Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005–2013) publication-title: Expert Opin Ther Pat doi: 10.1517/13543776.2013.780598 contributor: fullname: Supuran – volume: 1208 start-page: 127868 year: 2020 ident: CR39 article-title: Synthesis of novel organohalogen chalcone derivatives and screening of their molecular docking study and some enzymes inhibition effects publication-title: J Mol Struct doi: 10.1016/j.molstruc.2020.127868 contributor: fullname: Algul – volume: 31 start-page: 345 year: 2016 end-page: 360 ident: CR41 article-title: How many carbonic anhydrase inhibition mechanisms exist? publication-title: J Enzyme Inhib Med Chem doi: 10.3109/14756366.2015.1122001 contributor: fullname: Supuran – volume: 242 start-page: 4221 year: 1967 end-page: 4229 ident: CR21 article-title: Esterase activities of human carbonic anhydrases B and C publication-title: J Biol Chem contributor: fullname: Edsall – volume: 440 start-page: 463 year: 2006 end-page: 469 ident: CR34 article-title: hERG potassium channels and cardiac arrhythmia publication-title: Nature doi: 10.1038/nature04710 contributor: fullname: Tristani-Firouzi – ident: CR30 – volume: 99 start-page: 103762 year: 2020 ident: CR37 article-title: Novel functionally substituted esters based on sodium diethyldithiocarbamate derivatives: synthesis, characterization, biological activity and molecular docking studies publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2020.103762 contributor: fullname: Karaman – volume: 14 start-page: 667 year: 2004 end-page: 702 ident: CR13 article-title: Modulation of carbonic anhydrase activity and its applications in therapy publication-title: Expert Opın Ther Pat. doi: 10.1517/13543776.14.5.667 contributor: fullname: Supuran – volume: 227 start-page: 680 year: 1970 end-page: 685 ident: CR20 article-title: Cleavage of structural proteins during the assembly of the head of bacteriophage T4 publication-title: Nature doi: 10.1038/227680a0 contributor: fullname: Laemmli – volume: 85 start-page: 128 year: 2019 end-page: 139 ident: CR25 article-title: The first synthesis, carbonic anhydrase inhibition and anticholinergic activities of some bromophenol derivatives with S including natural products publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2018.12.012 contributor: fullname: Menzek – volume: 34 start-page: e22421 year: 2020 ident: CR24 article-title: In vitro effects of standard antioxidants on lactoperoxidase enzyme—a molecular docking approach publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.22421 contributor: fullname: Ozdemir – volume: 201 start-page: 121 year: 2007 end-page: 125 ident: CR7 article-title: The discovery of hypoglycemic sulfonamides publication-title: J Soc Biol doi: 10.1051/jbio:2007014 contributor: fullname: Loubatières-Mariani – volume: 112 start-page: 4421 year: 2012 end-page: 4468 ident: CR11 article-title: Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? publication-title: Chem Rev doi: 10.1021/cr200176r contributor: fullname: De Simone – volume: 72 start-page: 248 year: 1976 end-page: 254 ident: CR19 article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding publication-title: Anal Biochem doi: 10.1016/0003-2697(76)90527-3 contributor: fullname: Bradford – volume: 33 start-page: e22300 issue: 5 year: 2019 ident: CR17 article-title: Investigation of the effects of some sulfonamides on acetylcholinesterase and carbonic anhydrase enzymes publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.22300 contributor: fullname: Ozdemir – volume: 10 start-page: 925 year: 2003 end-page: 953 ident: CR4 article-title: Anticancer and antiviral sulfonamides publication-title: Curr Med Chem doi: 10.2174/0929867033457647 contributor: fullname: Supuran – volume: 23 start-page: 1828 year: 2015 end-page: 1840 ident: CR9 article-title: A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects publication-title: Bioorg Med Chem doi: 10.1016/j.bmc.2015.02.027 contributor: fullname: Supuran – volume: 6 start-page: 1149 year: 2014 end-page: 1165 ident: CR10 article-title: Sulfonamides and their isosters as carbonic anhydrase inhibitors publication-title: Future Med. Chem. doi: 10.4155/fmc.14.68 contributor: fullname: Scozzafava – volume: 23 start-page: 725 year: 2013 end-page: 735 ident: CR6 article-title: Antiobesity carbonic anhydrase inhibitors: a literature and patent review publication-title: Expert Opin Ther Pat doi: 10.1517/13543776.2013.790957 contributor: fullname: Carta – ident: CR23 – volume: 23 start-page: 737 year: 2013 end-page: 749 ident: CR5 article-title: Anticancer carbonic anhydrase inhibitors: a patent review (2008–2013) publication-title: Expert Opin Ther Pat doi: 10.1517/13543776.2013.798648 contributor: fullname: De Simone – volume: 86 start-page: 857 year: 2015 end-page: 863 ident: CR15 article-title: Some anti-ınflammatory agents ınhibit esterase activities of human carbonic anhydrase ısoforms i and II: an in vitro study publication-title: Chem Biol Drug Des doi: 10.1111/cbdd.12561 contributor: fullname: Beydemir – volume: 15 start-page: 4336 year: 2007 end-page: 4350 ident: CR14 article-title: Carbonic anhydrases as targets for medicinal chemistry publication-title: Bioorg Med Chem doi: 10.1016/j.bmc.2007.04.020 contributor: fullname: Scozzafava – volume: 176 start-page: 147 year: 1948 end-page: 154 ident: CR18 article-title: Electrometric and colorimetric determination of carbonic anhydrase publication-title: J Biol Chem contributor: fullname: Anderson – volume: 99 start-page: 103839 year: 2020 ident: CR38 article-title: Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1,2,3-triazole chalcone hybrids publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2020.103839 contributor: fullname: Angeli – volume: 1179 start-page: 709 year: 2019 end-page: 718 ident: CR31 article-title: Imidazolinium chloride salts bearing wingtip groups: synthesis, molecular docking and metabolic enzymes inhibition publication-title: J Mol Struct doi: 10.1016/j.molstruc.2018.11.038 contributor: fullname: Yigit – volume: 352 start-page: e1800359 year: 2019 ident: CR32 article-title: Synthesis, characterization, molecular docking and biological activities of novel pyrazoline derivatives publication-title: Arch Pharm doi: 10.1002/ardp.201800359 contributor: fullname: Gulcin – volume: 94 start-page: 103468 year: 2020 ident: CR27 article-title: Novel 2-methylimidazolium salts: synthesis, characterization, molecular docking, and carbonic anhydrase and acetylcholinesterase inhibitory properties publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2019.103468 contributor: fullname: Karaman – volume: 12 start-page: 137 year: 2018 ident: CR35 article-title: Therapeutic importance of synthetic thiophene publication-title: Chem Cent J doi: 10.1186/s13065-018-0511-5 contributor: fullname: Verma – volume: 56 start-page: 658 year: 1934 end-page: 666 ident: CR22 article-title: The determination of enzyme dissociation constants publication-title: J Am Chem Soc doi: 10.1021/ja01318a036 contributor: fullname: Burk – volume: 92 start-page: 103213 year: 2019 ident: CR29 article-title: Pyrazole[3,4-d]pyridazine derivatives: molecular docking and explore of acetylcholinesterase and carbonic anhydrase enzymes inhibitors as anticholinergics potentials publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2019.103213 contributor: fullname: Bildirici – year: 2019 ident: CR33 publication-title: Schrödinger, LLC, New York, NY, 2016 – volume: 22 start-page: 1642 year: 2017 ident: CR2 article-title: Special ıssue: sulfonamides publication-title: Molecules doi: 10.3390/molecules22101642 contributor: fullname: Supuran – volume: 12 start-page: 61 year: 2017 end-page: 88 ident: CR1 article-title: Advances in structure-based drug discovery of carbonic anhydrase inhibitors publication-title: Expert Opin Drug Discov doi: 10.1080/17460441.2017.1253677 contributor: fullname: Supuran – volume: 23 start-page: 677 year: 2013 end-page: 679 ident: CR12 article-title: Carbonic anhydrase inhibitors: an editorial publication-title: Expert Opin Ther Pat doi: 10.1517/13543776.2013.778246 contributor: fullname: Supuran – volume: 32 start-page: e22194 year: 2018 ident: CR16 article-title: 1H-indazole molecules reduced the activity of human erythrocytes carbonic anhydrase I and II isoenzymes publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.22194 contributor: fullname: Alım – volume: 29 start-page: 379 year: 2014 end-page: 387 ident: CR3 article-title: Sulfa and trimethoprim-like drugs-antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors publication-title: J Enzyme Inhib Med Chem doi: 10.3109/14756366.2013.787422 contributor: fullname: Supuran – ident: CR28 – volume: 46 start-page: 3 year: 2001 end-page: 26 ident: CR36 article-title: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings publication-title: Adv Drug Deliv Rev doi: 10.1016/S0169-409X(00)00129-0 contributor: fullname: Feeney – ident: CR26 – volume: 51 start-page: 302 year: 2015 end-page: 305 ident: CR40 article-title: Out of the active site binding pocket for carbonic anhydrase inhibitors publication-title: Chem Commun doi: 10.1039/C4CC07320G contributor: fullname: Vullo – volume: 201 start-page: 121 year: 2007 ident: 149_CR7 publication-title: J Soc Biol doi: 10.1051/jbio:2007014 contributor: fullname: MM Loubatières-Mariani – volume: 352 start-page: e1800359 year: 2019 ident: 149_CR32 publication-title: Arch Pharm doi: 10.1002/ardp.201800359 contributor: fullname: F Turkan – volume: 12 start-page: 137 year: 2018 ident: 149_CR35 publication-title: Chem Cent J doi: 10.1186/s13065-018-0511-5 contributor: fullname: R Shah – ident: 149_CR26 – volume-title: Schrödinger, LLC, New York, NY, 2016 year: 2019 ident: 149_CR33 contributor: fullname: Induced Fit Docking protocol; Glide – volume: 94 start-page: 103468 year: 2020 ident: 149_CR27 publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2019.103468 contributor: fullname: S Bal – ident: 149_CR30 – volume: 23 start-page: 737 year: 2013 ident: 149_CR5 publication-title: Expert Opin Ther Pat doi: 10.1517/13543776.2013.798648 contributor: fullname: SM Monti – volume: 23 start-page: 725 year: 2013 ident: 149_CR6 publication-title: Expert Opin Ther Pat doi: 10.1517/13543776.2013.790957 contributor: fullname: A Scozzafava – volume: 10 start-page: 925 year: 2003 ident: 149_CR4 publication-title: Curr Med Chem doi: 10.2174/0929867033457647 contributor: fullname: A Scozzafava – volume: 31 start-page: 345 year: 2016 ident: 149_CR41 publication-title: J Enzyme Inhib Med Chem doi: 10.3109/14756366.2015.1122001 contributor: fullname: CT Supuran – volume: 32 start-page: e22194 year: 2018 ident: 149_CR16 publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.22194 contributor: fullname: Z Alım – volume: 1179 start-page: 709 year: 2019 ident: 149_CR31 publication-title: J Mol Struct doi: 10.1016/j.molstruc.2018.11.038 contributor: fullname: B Yigit – volume: 99 start-page: 103839 year: 2020 ident: 149_CR38 publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2020.103839 contributor: fullname: P Singh – volume: 440 start-page: 463 year: 2006 ident: 149_CR34 publication-title: Nature doi: 10.1038/nature04710 contributor: fullname: MC Sanguinetti – volume: 46 start-page: 3 year: 2001 ident: 149_CR36 publication-title: Adv Drug Deliv Rev doi: 10.1016/S0169-409X(00)00129-0 contributor: fullname: CA Lipinski – volume: 34 start-page: e22421 year: 2020 ident: 149_CR24 publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.22421 contributor: fullname: R Kalin – volume: 1208 start-page: 127868 year: 2020 ident: 149_CR39 publication-title: J Mol Struct doi: 10.1016/j.molstruc.2020.127868 contributor: fullname: S Burmaoglu – volume: 23 start-page: 677 year: 2013 ident: 149_CR12 publication-title: Expert Opin Ther Pat doi: 10.1517/13543776.2013.778246 contributor: fullname: CT Supuran – volume: 15 start-page: 4336 year: 2007 ident: 149_CR14 publication-title: Bioorg Med Chem doi: 10.1016/j.bmc.2007.04.020 contributor: fullname: CT Supuran – volume: 12 start-page: 61 year: 2017 ident: 149_CR1 publication-title: Expert Opin Drug Discov doi: 10.1080/17460441.2017.1253677 contributor: fullname: CT Supuran – volume: 29 start-page: 379 year: 2014 ident: 149_CR3 publication-title: J Enzyme Inhib Med Chem doi: 10.3109/14756366.2013.787422 contributor: fullname: C Capasso – ident: 149_CR28 – volume: 22 start-page: 1642 year: 2017 ident: 149_CR2 publication-title: Molecules doi: 10.3390/molecules22101642 contributor: fullname: CT Supuran – volume: 23 start-page: 1828 year: 2015 ident: 149_CR9 publication-title: Bioorg Med Chem doi: 10.1016/j.bmc.2015.02.027 contributor: fullname: F Carta – volume: 86 start-page: 857 year: 2015 ident: 149_CR15 publication-title: Chem Biol Drug Des doi: 10.1111/cbdd.12561 contributor: fullname: Z Alım – volume: 85 start-page: 128 year: 2019 ident: 149_CR25 publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2018.12.012 contributor: fullname: C Bayrak – volume: 72 start-page: 248 year: 1976 ident: 149_CR19 publication-title: Anal Biochem doi: 10.1016/0003-2697(76)90527-3 contributor: fullname: MM Bradford – volume: 227 start-page: 680 year: 1970 ident: 149_CR20 publication-title: Nature doi: 10.1038/227680a0 contributor: fullname: UK Laemmli – volume: 99 start-page: 103762 year: 2020 ident: 149_CR37 publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2020.103762 contributor: fullname: A Karimov – volume: 92 start-page: 103213 year: 2019 ident: 149_CR29 publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2019.103213 contributor: fullname: P Taslimi – volume: 33 start-page: e22300 issue: 5 year: 2019 ident: 149_CR17 publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.22300 contributor: fullname: Z Koksal – volume: 14 start-page: 667 year: 2004 ident: 149_CR13 publication-title: Expert Opın Ther Pat. doi: 10.1517/13543776.14.5.667 contributor: fullname: A Scozzafava – volume: 242 start-page: 4221 year: 1967 ident: 149_CR21 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)95800-X contributor: fullname: JA Verpoorte – volume: 112 start-page: 4421 year: 2012 ident: 149_CR11 publication-title: Chem Rev doi: 10.1021/cr200176r contributor: fullname: V Alterio – volume: 6 start-page: 1149 year: 2014 ident: 149_CR10 publication-title: Future Med. Chem. doi: 10.4155/fmc.14.68 contributor: fullname: F Carta – volume: 56 start-page: 658 year: 1934 ident: 149_CR22 publication-title: J Am Chem Soc doi: 10.1021/ja01318a036 contributor: fullname: H Lineweaver – volume: 23 start-page: 681 year: 2013 ident: 149_CR8 publication-title: Expert Opin Ther Pat doi: 10.1517/13543776.2013.780598 contributor: fullname: F Carta – ident: 149_CR23 – volume: 51 start-page: 302 year: 2015 ident: 149_CR40 publication-title: Chem Commun doi: 10.1039/C4CC07320G contributor: fullname: K D’Ambrosio – volume: 176 start-page: 147 year: 1948 ident: 149_CR18 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)51011-5 contributor: fullname: KM Wilbur |
SSID | ssj0041235 |
Score | 2.4247854 |
Snippet | Background
Thiophene(s) are an important group in therapeutic applications, and sulfonamides are the most important class of carbonic anhydrase (CA)... BACKGROUNDThiophene(s) are an important group in therapeutic applications, and sulfonamides are the most important class of carbonic anhydrase (CA) inhibitors.... |
SourceID | proquest crossref springer |
SourceType | Aggregation Database Publisher |
StartPage | 1738 |
SubjectTerms | Drug Safety and Pharmacovigilance Medicine Pharmacotherapy Pharmacy |
Title | Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies |
URI | https://link.springer.com/article/10.1007/s43440-020-00149-4 https://search.proquest.com/docview/2430379488 |
Volume | 72 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtpAFB3RZNNN1adK-tCtVGUDrsAMY3sZKlBoU9oFSCgba2yPBUqwEYaF80X9hn5d7x2PH0mjKu3GGtnMGOkc38fMfTD2Meh5YTh0lCWcwEYHZehaMhL4uQceVaJ1hBfqap8zcb7gX5bDZav1sxG1dNgHn8Kbe_NK_gdVvIe4UpbsPyBbLYo3cIz44hURxuuDMB5XpbrJ5svSjUI7ck2VAhJlkX6KKPo8TqnpfKQy6imzTfd0-r9OVutgrTvtUFy53AW6E45MVnm0w4mdaREoPO2ss1QlNznVdMLhtSQLVeekFN391C6nTgthTvu3aMpeodVa1oDdlK13i34718XWRR23aGziH3X1bM0Yc4xRUVGbv6O-Ju7lYSWrmJCvdMo_EleZblrQuVR5orbVQ7mTZnf3G07abEymt9nhsJvRIoVQdgbcQr-t15Tajt1gZ1ME46_dhjpHj8u9V1UU0SEZH9DpNr1Ve4sm5ehWXe7Zd3-yuLjw5-Pl_BE7tlGkoSw9PpuMRrNS63PKOdbJt-a_mgQtnab5xztuG0G1Z3PnMF7bOPOn7IlxTuCsYNoz1lLJc3Zq8Mm7MK-T9bIunEIDufwF-1XTEdIYiI5wh47QpCPIDAo6Qk1HmlnSESo6whTHEUynUNMRSjoC0RE0HaFJRwhyMHTUsys6QkVHMHR8yRaT8fzzuWVag1ghegB7yw7igDuxiKgeZN8RgefGYQ-FDo8U78cC1b8r7VCInq1Cz7P7IeolqQJHkAsjosErdpSkiXrNIOL4UAhvGPVjLmLlxo5CvSddbnMle6rNOiVW_raoAONXtb41sj4i62tkfd5mH0o4fRTUdPomE5UeMt_maC2i9nPdNuuWOPtGmmR_WfLkAUu-YY_rL-ctO9rvDuodWsv74L0h6m8y5sf7 |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+some+thiophene-based+sulfonamides+as+potent+inhibitors+of+carbonic+anhydrase+I+and+II+isoenzymes+isolated+from+human+erythrocytes+by+kinetic+and+molecular+modelling+studies&rft.jtitle=Pharmacological+reports&rft.au=Al%C4%B1m%2C+Zuhal&rft.au=K%C3%B6ksal%2C+Zeynep&rft.au=Karaman%2C+Muhammet&rft.date=2020-12-01&rft.issn=1734-1140&rft.volume=72&rft.issue=6&rft.spage=1738&rft.epage=1748&rft_id=info:doi/10.1007%2Fs43440-020-00149-4&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1734-1140&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1734-1140&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1734-1140&client=summon |